Analysts/Institutional Investor Meet/Con. Call Updates

Date: August 19, 2026 Ref. No.: KDL/SE/034/2026-27 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 400051 Scrip Code: 543328 NSE Symbol: KRSNAA Dear Sir/Madam, Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 for Transcript of Earnings Call for quarter ended June 30, 2026. Pursuant to the Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call held with the analysts and investors on Friday, August 14, 2026 at 13:00 Hrs. (IST) to discuss the Unaudited (Standalone and Consolidated) Financial Results for the quarter ended June 30, 2026. The above information will also be made available on the website of the Company at https://krsnaadiagnostics.com/investors. Request you to take the same on your records. Thanking you, Yours sincerely, For Krsnaa Diagnostics Limited Sujoy Sudipta Bose Company Secretary & Compliance Officer Encl: as above “Krsnaa Diagnostics Limited Q1 FY27 Earnings Conference Call” August 14, 2026 MANAGEMENT: MR. YASH MUTHA – MANAGING DIRECTOR – KRSNAA DIAGNOSTICS LIMITED MR. MITESH DAVE – GROUP CHIEF EXECUTIVE OFFICER – KRSNAA DIAGNOSTICS LIMITED MR. CHANDRA PRAKASH – INTERIM CHIEF FINANCIAL OFFICER – KRSNAA DIAGNOSTICS LIMITED Page 1 of 18 Krsnaa Diagnostics Limited August 14, 2026 Moderator: Ladies and gentlemen, good day, and welcome to Krsnaa Diagnostics Limited Q1 FY27 Earnings Conference Call, hosted by Equirus Securities. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star, then zero on your touch-tone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Yash Mutha from Krsnaa Diagnostics Limited. Thank you, and over to you, sir. Yash Mutha: Thank you, Sumit. Good afternoon, everyone, and thank you for joining us. As we begin the FY27, I want to start with the larger vision behind what we are building at Krsnaa Diagnostics. We've always believed that diagnostics is an essential part of India's health care infrastructure. Our ambition is simple: to make quality diagnostics accessible to every Indian, irrespective of where they live or their ability to pay. The purpose has taken us to parts of India where building and operating health care infrastructure is not always easy. Think about what happens in Rajasthan today. A patient gives a sample in a remote location. The sample may travel significant distances across the state before reaching our laboratories, where it is processed, validated and reported back to the patient. Behind that one report is the infrastructure network, logistics, technology, clinical expertise and execution working together. If serving these markets were easy, health care access in many parts of India would have already been solved. Someone has to go there. Someone has to build the laboratory network or the imaging network. Someone has to establish the collection centers. Someone has to create the logistics network and connect the technology and the clinical expertise. Krsnaa has chosen to be that someone. And what excites me today is that purpose is increasingly translating into business performance. Our revenue grew approximately 22% year-on-year in Q1. More importantly, our like- to-like projects grew approximately 12%. That number matters to me. It demonstrates that Krsnaa's growth is not dependent only upon winning the next project. Infrastructure that we have already established continues to serve more patients and generate more businesses. On the same lines, I'm also pleased to share that Krsnaa has recently been awarded the Himachal Pradesh CT project for 34 CT scans across the entire state. This is Page 2 of 18 Krsnaa Diagnostics Limited August 14, 2026 particularly significant for us because Himachal Pradesh is where Krsnaa began its PPP journey almost 12 years ago with just 12 centers. Our performance and service quality over the years have earned us this opportunity to expand our footprint from 12 to 34 centers. And predominantly, most of this project is going to be a cash paying project. This is a strong validation of something we have consistently communicated. Execution excellence and quality of service create the foundation for repeat business and long-term partnerships. With this award, we are further strengthening our revenue visibility in the state for the next 10 years and giving Krsnaa the opportunity to serve the people of Himachal Pradesh for almost 25 years in total. There is also a third dimension emerging. Our retail business grew approximately 64% year-on-year. Our retail network has expanded to more than 4,000-plus touch points, and we are seeing increasing contributions from home collection, wellness camps, digital channels and our partner networks. For many years, Krsnaa's strength has been its institutional business. We are now building a second engine alongside it, the consumer-facing cash paying business. One gives us scale and reach. The other gives us diversification and a direct relationship with the consumers. And increasingly, innovation will connect both. We are also looking beyond the conventional diagnostics packages and asking a different question, how can diagnostics become a part of the consumers' broader health. I am particularly excited about what comes next. Very shortly, we will be launching what we believe is the first-of-a-kind proposition in India, bringing together preventive diagnostics and financial protection in a single offering. We believe this can create an entirely new dimension of how consumers engage with Krsnaa and with preventive health care. We are also expanding the use of artificial intelligence and technology across consumer engagement, X-ray reporting and business analytics. So when I look at Krsnaa today, I see something very different from the company we were a few years ago. I see an existing health care infrastructure that is growing organically. I see new projects adding another layer of growth, and I also see consumer business emerging as a second engine, and I see technology and innovation creating new possibilities on top of this network. As regards our margins, as mentioned in the previous quarters, due to the project implementations, they also carry their full fixed cost base from the very first day in laboratory equipment, the manpower and the logistics, while still operating below mature utilization levels, and therefore, you see Page 3 of 18 Krsnaa Diagnostics Limited August 14, 2026 compression in the margins. However, if we set these projects aside, our like-to-like business delivered stable and consistent margins broadly in line with the previous quarters. So the moderation you see is largely a function of the infrastructure that we have recently built and now are in the process of fulfilling it rather than any pricing or structural pressure in the core business. A related point on capital, ours is an infrastructure-led model and by nature, the capital expenditure is front-ended. We build the laboratory or the diagnostics network, install the equipment and put the team in place before the volumes arrive. That front ending creates a drag on the margins in the initial quarters, which is essentially what you are seeing in the quarter's numbers. As these projects ramp up and utilization improves, that drag evens out and the incremental revenues begin to flow into an asset base that is already in place. That is the rhythm [Showing first 8,000 characters — download PDF for full document]